COMMUNIQUÉS West-GlobeNewswire

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
17/09/2025
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that 48-week clinical data from the [...]
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
17/09/2025
Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior lines of therapy including anti-PD-1 Recommended phase 2 dose (RP2D) [...]
NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1
17/09/2025
Les données ont montré un profil de sécurité favorable et des signaux préliminaires d’efficacité dans une population lourdement prétraitée dont le cancer était en progression malgré plusieurs lignes de traitement, [...]
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
17/09/2025
Atlanta, GA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ) today announced it has completed the repurchase of 366,359 shares [...]
Vaxart Appoints W. Mark Watson as Lead Independent Director
17/09/2025
In process of adopting a Director stock ownership policy to reinforce commitment of aligning the Board’s interests with stockholders Vaxart encourages all stockholders of record on July 29, 2025, who have not yet voted [...]
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
17/09/2025
REDWOOD CITY, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Are Women on the Frontline of Antimicrobial Resistance?
17/09/2025
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- National Patient Survey of Women’s Urinary Tract Infection (UTI) and Prenatal Screening reveals women suffering from UTI concerned about immediate antibiotic prescribing and [...]
The Association of American Physicians and Surgeons (AAPS) Supports HHS Secretary Kennedy and Making America Healthy Again (MAHA)
17/09/2025
TUCSON, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) -- On September 13, at its 82 nd annual meeting in Chantilly, VA, the Association of American Physicians and Surgeons (AAPS) passed the following emergency resolution, [...]
Amid 7-OH Health Warnings, Happy Go Leafy Introduces Pure Kratom Line for Safer Wellness
17/09/2025
Happy Go Leafy responds to 7-OH concerns with a new pure kratom line. Lab-tested and transparent products designed to support safer wellness use. Miami, Florida, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 2025 has seen urgent [...]
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
17/09/2025
Representing 10 U.S. states and Puerto Rico, finalists will compete in Washington, D.C., for more than $100,000 in awards WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 [...]
Esteworld Concludes Four-Day Consultation Series at Covent Garden, London
17/09/2025
Photo: Esteworld Representative Office - Covent Garden, London LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Esteworld Health Group has concluded a four-day series of face-to-face consultation sessions at its Covent Garden [...]

Pages